The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cyclophosphamide, and prednisone) were superior to pla...
Main Authors: | Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1994
|
Similar Items
-
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
by: Noseworthy, J, et al.
Published: (2001) -
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
by: Nosworthy, J, et al.
Published: (2001) -
ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
by: Noseworthy, J, et al.
Published: (1989) -
Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
by: Noseworthy, J, et al.
Published: (1989) -
A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
by: Noseworthy, J, et al.
Published: (1989)